Chemours Co (NYSE:CC) had its Buy rating reiterated by Citigroup with a $43.00 price target

ME Staff
-
0

Analyst Ratings For Chemours Co (NYSE:CC)

Today, Citigroup reiterated its Buy rating on Chemours Co (NYSE:CC) with a price target of $43.00.

There are 6 Buy Ratings, 3 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Chemours Co (NYSE:CC) is Buy with a consensus target price of $48.1250 per share, a potential 27.99% upside.

Some recent analyst ratings include

  • 2/20/2019-Chemours Co (NYSE:CC) had its Buy rating reiterated by Citigroup with a $43.00 price target
  • 2/19/2019-Chemours Co (NYSE:CC) had its Positive ➝ Neutral rating reiterated by Susquehanna Bancshares with a $37.00 price target
  • 1/15/2019-Chemours Co (NYSE:CC) had its Buy rating reiterated by Barclays with a $48.00 price target
  • 1/8/2019-Chemours Co (NYSE:CC) has coverage initiated with a Buy ➝ Buy rating and $52.00 price target
  • On 12/3/2018 Richard H. Brown, Director, bought 10,000 with an average share price of $28.60 per share and the total transaction amounting to $286,000.00.
  • On 5/9/2018 Mark P Vergnano, Insider, sold 200,151 with an average share price of $50.47 per share and the total transaction amounting to $10,101,620.97.
  • On 5/8/2018 Mark Newman, CFO, sold 43,675 with an average share price of $50.04 per share and the total transaction amounting to $2,185,497.00.
  • On 4/17/2018 Erich Parker, SVP, sold 5,000 with an average share price of $52.00 per share and the total transaction amounting to $260,000.00.
  • On 3/9/2018 Mark Newman, VP, sold 29,381 with an average share price of $49.19 per share and the total transaction amounting to $1,445,251.39.
  • On 2/20/2018 Paul Kirsch, Insider, sold 13,770 with an average share price of $50.01 per share and the total transaction amounting to $688,637.70.
  • On 12/13/2017 Christian W. Siemer, Insider, sold 15,088 with an average share price of $47.37 per share and the total transaction amounting to $714,718.56.

About Chemours Co (NYSE:CC)
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Recent Trading Activity for Chemours Co (NYSE:CC)
Shares of Chemours Co closed the previous trading session at 37.60 −0.15 0.40% with 2882000 shares trading hands.